Equity Research • May 31, 2026

HealthEquity, Inc.

America’s #1 HSA Administrator — Durable Custodial Flywheel With Rate Optionality
TickerHQY
ExchangeNASDAQ
RatingBUY
Price Target$155
Current Price$120.40
Upside+28.7%
Market Cap$6.4B
SectorHealthcare Technology
52-Week Range
$82 – $136
At 52W high territory
FY27E Revenue
$1.39B
+7% YoY guidance midpoint
Adj. EBITDA Margin
44.1%
FY27E; expanding +80bps
HSA Accounts
9.8M+
+14% YoY; largest US custodian
Custodial AUM
$28.4B
+22% YoY; interest-bearing
FY27E Adj. EPS
$5.30
22x FY27E = $115 floor
FCF Yield
7.0%
FY27E FCF ~$450M / $6.4B MCap
Smart Score
8 / 10
Outperform vs. market
Investment Thesis
HealthEquity is the undisputed leader in health savings account (HSA) administration with 9.8M+ accounts and $28.4B in custodial assets under management — nearly double its nearest competitor. The business operates a self-reinforcing flywheel: employer wins generate new member accounts, accounts accumulate cash balances that earn spread revenue, members invest balances in mutual funds generating fee revenue, and scale drives operating leverage that funds further sales capacity. Three structural tailwinds converge: (1) secular HSA account growth driven by high-deductible health plan adoption (now 55%+ of employer-sponsored coverage), still penetrating less than 40% of eligible workforce; (2) custodial yield expansion as HSA cash balances reset to higher rates on rolling 2-4 year deposit agreements; and (3) WageWorks integration delivering SG&A synergies still being harvested through consolidated technology infrastructure. At 22x FY28E EPS of $6.55 and 20x FY28E FCF, the stock screens cheap versus its durable, asset-light earnings profile. We rate HQY BUY with a $155 12-month price target.
HSA Market Leader Custodial Spread Leverage HDHP Secular Growth WageWorks Synergies Asset-Light FCF Benefits Ecosystem
Income Statement Forecast (FY ends Jan 31, $ millions)
Metric FY24AFY25AFY26A FY27EFY28EFY29E
Revenue Breakdown
Service Revenue$416$434$456$475$502$532
Custodial Revenue$542$634$668$730$810$895
Interchange Revenue$162$172$176$185$196$209
Total Revenue$1,120$1,240$1,300$1,390$1,508$1,636
  YoY Growth—+10.7%+4.8%+6.9%+8.5%+8.5%
Profitability
Gross Profit$756$862$910$979$1,070$1,168
  Gross Margin67.5%69.5%70.0%70.4%71.0%71.4%
Technology & Dev($142)($148)($154)($160)($166)($173)
SG&A($284)($295)($305)($315)($330)($348)
Adj. EBITDA$458$521$559$613$688$768
  Adj. EBITDA Margin40.9%42.0%43.0%44.1%45.6%46.9%
D&A($96)($102)($108)($112)($116)($121)
Adj. EBIT$362$419$451$501$572$647
  EBIT Margin32.3%33.8%34.7%36.0%37.9%39.5%
Interest & Other (Net)$18$22$24$26$30$35
Adj. Pre-Tax Income$380$441$475$527$602$682
Taxes (~22%)($84)($97)($105)($116)($132)($150)
Adj. Net Income$196$244$270$304$350$399
Diluted Shares (M)55.454.053.353.053.554.0
Adj. EPS (Diluted)$3.54$4.52$5.07$5.74$6.54$7.39
Balance Sheet & Cash Flow Forecast ($ millions)
Balance Sheet FY25AFY26AFY27EFY28E
Assets
Cash & Equivalents$312$338$390$475
Accounts Receivable$90$96$103$112
Other Current Assets$48$52$55$59
Goodwill & Intangibles$3,240$3,132$3,025$2,918
PP&E & Other$224$218$213$210
Total Assets$3,914$3,836$3,786$3,774
Liabilities & Equity
Current Liabilities$244$258$268$280
Long-Term Debt$1,148$998$848$698
Other LT Liabilities$136$128$121$114
Shareholders’ Equity$2,386$2,452$2,549$2,682
Net Debt / (Cash)$836$660$458$223
  Net Debt / EBITDA1.6x1.2x0.7x0.3x
Cash Flow FY25AFY26AFY27EFY28E
Adj. Net Income$244$270$304$350
D&A & Amortization$192$196$200$204
Stock-Based Comp$68$72$74$76
Working Capital Changes($22)($18)($15)($16)
Operating Cash Flow$482$520$563$614
CapEx & Internal Dev($124)($118)($114)($112)
Free Cash Flow$358$402$449$502
  FCF Margin28.9%30.9%32.3%33.3%
Debt Repayment($150)($150)($150)($150)
Share Repurchases($48)($52)($60)($70)
Net Change in Cash$160$200$239$282
FCF / Adj. Net Income147%149%148%143%
Charts

Revenue & Adj. EBITDA Margin (FY24A–FY29E)

Price History & 12-Month Price Target

Valuation & Peer Comparison

Our Valuation Framework

MethodMultipleMetricImplied PT
P/E (FY28E)23.5x$6.54 EPS$154
EV/EBITDA (FY27E)12.5x$613M$148
EV/FCF (FY27E)15.0x$449M$152
DCF (10% WACC, 3% TGR)—FCF $449M+$162
Blended / Base PT——$155

Business Model Key Metrics

KPIFY25AFY26AFY27E
HSA Accounts (M)8.69.39.8
Custodial AUM ($B)$23.2$28.4$34.0
AUM / Account ($K)$2.70$3.05$3.47
Custodial Yield2.73%2.35%2.15%
Net Rev / Member$144$140$142
Interchange / Account$20$19$19
Company TickerMkt CapEV/EBITDA NTMP/E NTMRev GrowthEBITDA MarginFCF Yield
HealthEquityHQY$6.4B11.8x21x+7%44%7.0%
Benefytt TechnologiesBFYT$0.5B14xnmf+5%28%4.2%
Wageworks (legacy comp)——15x25x+6%40%5.5%
Evolent HealthEVH$2.8B13x22x+12%15%3.8%
Veeva SystemsVEEV$33B28x35x+15%40%3.5%
Broadridge FinancialBR$24B18x26x+7%22%3.2%
HQY trades at a 20-25% discount to financial-tech software peers on EV/EBITDA despite higher margins and faster FCF conversion. Discount reflects rate sensitivity concerns and slower near-term revenue growth, which we view as a buying opportunity.
Price Target Scenarios
▲ Bull Case
$200
+66% upside • 25% probability
Fed rate hikes extend custodial yields; HSA accounts accelerate to 11M+ on new Medicare HSA eligibility legislation. EBITDA margin expands to 48%+. EV/EBITDA re-rates to 15x. Debt fully retired by FY28.
■ Base Case
$155
+28.7% upside • 55% probability
Steady HSA account growth 9-10% annually, custodial yields stabilize near 2.1-2.3%, EBITDA margin expands 80-100bps annually. Net debt approaches zero by FY29. 23x FY28E EPS of $6.54.
▼ Bear Case
$78
-35% downside • 20% probability
Fed cuts rates aggressively, custodial yield compresses below 1.5% — $130M headwind to revenue. HSA market commoditization pressures Service revenue pricing. EBITDA margin falls to 38%. Re-rates to 16x EBITDA.
Key Catalysts (Next 12 Months)
Q2 FY27 Earnings (Sept 2026)
Aug–Sep 2026 • HIGH IMPACT
Open enrollment season begins Sep/Oct; Q2 results will show early pipeline signals. Custodial yield guidance update critical — any upward revision will be a major positive catalyst. Watch for AUM growth vs. prior year sequentially.
Open Enrollment Season (Oct–Dec 2026)
Oct–Dec 2026 • HIGH IMPACT
The single biggest driver of new account additions. Employee elections into HDHPs drive new HSA accounts. Employer wins announced during this window set the trajectory for FY28. Consensus expects ~700K net new accounts in H2 FY27.
Federal HSA Legislation
H2 2026 • MEDIUM IMPACT
Several bills in Congress propose expanding HSA eligibility: Medicare Part A enrollees, direct primary care members, and veterans. CBO-scored bills could add 5-10M incremental eligible participants — representing $500M+ in TAM expansion for HQY.
Technology Platform Consolidation
FY27–FY28 • MEDIUM IMPACT
HQY is migrating WageWorks FSA/COBRA/Commuter accounts onto its unified benefitWallet platform. Completion drives $20-25M in ongoing OpEx savings and improves member NPS, reducing account attrition risk at renewal.
Investment Menu Expansion
Ongoing • MEDIUM IMPACT
Self-directed brokerage accounts (SDBA) growing 40%+ YoY. Average investable balance holders generate 3x revenue per account vs. cash-only holders. Every 1% shift from cash to investments adds ~$15M in incremental fee revenue annually.
Debt-Free Milestone (FY29)
FY29 Target • MEDIUM IMPACT
Net debt approaching zero by FY29E enables capital return acceleration: share buybacks or special dividends. Current $150M annual debt repayment converts directly to buyback capacity upon payoff. Initiating a dividend remains on management’s radar.
Risk Register
Interest Rate / Custodial Yield Risk
Severity: HIGH • Probability: MEDIUM
~48% of revenue is custodial (spread income on HSA cash balances). Every 25bps rate cut reduces custodial revenue by ~$35-40M annually. If Fed cuts 150bps in 2026-27, total custodial revenue headwind could reach $200M+. Partially mitigated by 2-4 year fixed deposit agreements (~70% locked in) but significant floating exposure remains.
HSA Market Commoditization
Severity: HIGH • Probability: LOW-MEDIUM
Large health insurers (UHG, Cigna, Anthem) have built competing HSA platforms. Fidelity offers fee-free HSA accounts. Aggressive pricing by hyperscale competitors could pressure HQY’s per-member revenue and retention rates at large employer renewals. Scale advantages partially offset risk.
HDHP / ACA Regulatory Risk
Severity: MEDIUM • Probability: LOW
Policy shifts unfavorable to HDHPs (e.g., mandating first-dollar coverage requirements) would reduce new HSA account formation. Legislative changes requiring HSAs to cover more services pre-deductible could limit eligible account growth. HQY management monitors 20+ bills in Congress.
Technology / Cybersecurity Risk
Severity: MEDIUM • Probability: MEDIUM
HQY administers $28B+ in sensitive financial/health data. A significant data breach could impair employer trust, lead to regulatory penalties (HIPAA), and trigger large employer contract losses at renewal. Outage of the benefitWallet platform during open enrollment would be particularly damaging.
WageWorks Integration Execution
Severity: MEDIUM • Probability: LOW
Remaining technology migrations carry execution risk: customer service degradation, temporary attrition during platform transitions. Management recently disclosed ~$8M in transition costs remaining. Any service disruption during open enrollment season would be disproportionately costly.
Goodwill Impairment Risk
Severity: LOW • Probability: LOW
$3.0B in goodwill/intangibles (~79% of total assets) from the WageWorks acquisition ($4.3B in 2019). A sustained deterioration in HSA market conditions or prolonged rate compression could trigger non-cash impairment charges, which would impact reported earnings but not FCF or operations.
Market Sentiment & Positioning
Analyst Consensus
BUY
18 Buy / 4 Hold / 1 Sell
Avg. Price Target
$148
Range: $96 – $195
Short Interest
5.8%
Of float; moderate positioning
Institutional Ownership
93%
Heavily institutionally held
Insider Sentiment
Bullish
CEO purchased $2.1M Q1 2026
Hedge Fund Trend
Adding
Net new positions Q4 2025
Sentiment Context: HQY has outperformed healthcare IT peers YTD (+38% vs. +12%) following Q4 FY26 earnings beat and raised FY27 guidance. The stock trades near a 52-week high but still well below its 2021 peak of $105 (pre-rate sensitivity reset). The bear case has largely played out — custodial yields have reset lower, WageWorks integration costs have peaked, and the multiple compressed from 35x to 21x NTM earnings. At current prices, we think the risk/reward is compelling for patient investors with an 18-24 month horizon as the debt paydown and rate normalization thesis plays out.

Bottom Line: BUY | $155 Price Target

HealthEquity is structurally advantaged as the HSA market leader with 9.8M accounts and $28.4B in custodial AUM — metrics that compound organically as long as HDHPs remain the dominant employer health plan. The bear case of rate compression and commoditization has been priced in: HQY trades at just 11.8x NTM EBITDA against 43-44% margins and a FCF yield approaching 7%. What the market underappreciates is the AUM balance flywheel: as member accounts season (average account age >5 years), cash balances grow, investable balances grow faster, and per-member economics expand durably. With debt approaching zero by FY29, an inflection in capital return is coming. We set a $155 base-case PT on 23.5x FY28E EPS of $6.54, and see a credible path to $200 if HSA legislation tailwinds materialize. Risk/reward is 2:1+ in our favor.

Disclaimer: This report is generated for informational and educational purposes only. It does not constitute investment advice, a solicitation, or an offer to buy or sell any security. All financial forecasts are estimates subject to change. Past performance is not indicative of future results. Investors should conduct their own due diligence and consult a qualified financial advisor before making investment decisions. Sources: TipRanks, SEC filings (10-K, 10-Q), HealthEquity earnings releases, company investor presentations, Wall Street consensus estimates. Prices as of May 31, 2026.